141 related articles for article (PubMed ID: 7825652)
1. Human lymphocyte antigens in Graves' disease: correlation with persistent course of disease.
Baldini M; Pappalettera M; Lecchi L; Orsatti A; Meroni L; Tozzi R; Scalamogna M; Cantalamessa L
Am J Med Sci; 1995 Jan; 309(1):43-8. PubMed ID: 7825652
[TBL] [Abstract][Full Text] [Related]
2. The role of HLA antigens in the manifestation and course of Graves' disease.
Stenszky V; Kozma L; Balazś C; Bear JC; Farid NR
Mol Biol Med; 1986 Feb; 3(1):53-62. PubMed ID: 3485758
[TBL] [Abstract][Full Text] [Related]
3. Genetic factors in Graves' ophthalmopathy.
Frecker M; Stenszky V; Balazs C; Kozma L; Kraszits E; Farid NR
Clin Endocrinol (Oxf); 1986 Nov; 25(5):479-85. PubMed ID: 3113776
[TBL] [Abstract][Full Text] [Related]
4. Graves' disease and HLA: clinical and epidemiologic associations.
Farid NR; Stone E; Johnson G
Clin Endocrinol (Oxf); 1980 Dec; 13(6):535-44. PubMed ID: 6894412
[TBL] [Abstract][Full Text] [Related]
5. HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course.
Dahlberg PA; Holmlund G; Karlsson FA; Säfwenberg J
Acta Endocrinol (Copenh); 1981 May; 97(1):42-7. PubMed ID: 6164233
[TBL] [Abstract][Full Text] [Related]
6. Human lymphocyte antigens (HLA) and Graves' disease in Turkey.
Orhan Y; Azezli A; Carin M; Aral F; Sencer E; Molvalilar S
J Clin Immunol; 1993 Sep; 13(5):339-43. PubMed ID: 7902362
[TBL] [Abstract][Full Text] [Related]
7. Immunogenetic markers in patients with Graves' disease.
Schifferdecker E; Kühnl P; Schöffling K; Manfras B; Holzberger G; Spielmann W; Böhm BO
Klin Wochenschr; 1991 Apr; 69(6):256-60. PubMed ID: 2038175
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR3 and DRw6: prognostic factors for the incidence of hypothyroidism in Graves' disease after radioiodine treatment.
Althaus B; Straub JJ; Neri TM; Hauenstein M; Müller-Brand J; Berger W; Farid NR
Acta Endocrinol (Copenh); 1986 Nov; 113(3):323-8. PubMed ID: 3788412
[TBL] [Abstract][Full Text] [Related]
9. The association of HLA with autoimmune thyroid disease in Newfoundland. The influence of HLA homozygosity in Graves' disease.
Farid NR; Barnard JM; Marshall WH
Tissue Antigens; 1976 Sep; 8(3):181-9. PubMed ID: 989647
[TBL] [Abstract][Full Text] [Related]
10. HLA antigens in Asian Indian patients with Graves' disease.
Tandon N; Mehra NK; Taneja V; Vaidya MC; Kochupillai N
Clin Endocrinol (Oxf); 1990 Jul; 33(1):21-6. PubMed ID: 2401095
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR3 and HLA-DR5 associated thyrotoxicosis--two different types of toxic diffuse goiter.
Schleusener H; Schernthaner G; Mayr WR; Kotulla P; Bogner U; Finke R; Meinhold H; Koppenhagen K; Wenzel KW
J Clin Endocrinol Metab; 1983 Apr; 56(4):781-5. PubMed ID: 6131902
[TBL] [Abstract][Full Text] [Related]
12. Graves' disease: immunological and immunogenetic indicators of relapse.
de Bruin TW; Bolk JH; Bussemaker JK; Stijnen T; Schreuder GM; de Vries RR; van der Heide D
Br Med J (Clin Res Ed); 1988 May; 296(6632):1292-5. PubMed ID: 3133054
[TBL] [Abstract][Full Text] [Related]
13. C4A gene deletion: association with Graves' disease.
Ratanachaiyavong S; Lloyd L; McGregor AM
J Mol Endocrinol; 1989 Sep; 3(2):145-53. PubMed ID: 2570594
[TBL] [Abstract][Full Text] [Related]
14. HLA and Graves' disease: an association with HLA-DRw3.
Allannic H; Fauchet R; Lorcy Y; Heim J; Gueguen M; Leguerrier AM; Genetet B
J Clin Endocrinol Metab; 1980 Oct; 51(4):863-7. PubMed ID: 6932402
[TBL] [Abstract][Full Text] [Related]
15. T lymphocyte subsets at various stages of hyperthyroid Graves' disease: effect of carbimazole treatment and relationship with thyroid-stimulating antibody levels or HLA status.
Madec AM; Allannic H; Genetet N; Gueguen M; Genetet G; Fauchet R; Stefanutti A; Orgiazzi J
J Clin Endocrinol Metab; 1986 Jan; 62(1):117-21. PubMed ID: 3484386
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity by cluster analysis techniques of Graves' patients typed for HLA DR and IgG heavy chain markers.
Frecker MF; Preus M; Kozma L; Krasrits E; Stenszky V; Balazś C; Farid NR
Mol Biol Med; 1986 Feb; 3(1):63-71. PubMed ID: 3083192
[TBL] [Abstract][Full Text] [Related]
17. Certain HLA alleles are associated with stress-triggered Graves' disease and influence its course.
Vita R; Lapa D; Trimarchi F; Vita G; Fallahi P; Antonelli A; Benvenga S
Endocrine; 2017 Jan; 55(1):93-100. PubMed ID: 26951052
[TBL] [Abstract][Full Text] [Related]
18. HLA antigens in Greek patients with thyrotoxicosis (Graves' disease and toxic nodular goiter).
Papasteriades C; Alevizaki-Harhalaki MN; Economidou J; Ikkos DG
J Endocrinol Invest; 1984 Aug; 7(4):283-6. PubMed ID: 6594386
[TBL] [Abstract][Full Text] [Related]
19. A prospective study of the relationship between relapse of hyperthyroid Graves' disease after antithyroid drugs and HLA haplotype.
Allannic H; Fauchet R; Lorcy Y; Gueguen M; Le Guerrier AM; Genetet B
J Clin Endocrinol Metab; 1983 Oct; 57(4):719-22. PubMed ID: 6688428
[TBL] [Abstract][Full Text] [Related]
20. Class III alleles and high-risk MHC haplotypes in type I diabetes mellitus, Graves' disease and Hashimoto's thyroiditis.
Skanes VM; Barnard J; Farid N; Marshall WH; Murphy L; Rideout D; Taylor R; Xidos G; Larsen B
Mol Biol Med; 1986 Apr; 3(2):143-57. PubMed ID: 3461234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
